The Drug Controller General of India (DCGI) approved the use of the Russian Sputnik V vaccine against coronavirus in the country on April 12. Now, India has three vaccines Covishield, Covaxin and Sputnik V for its inoculation programme against COVID-19.

As many as 25,462 fresh COVID-19 cases and 161 deaths were reported in Delhi in the last 24 hours, taking the total active cases in Delhi to 74,941.

India too reported its highest-ever single-day spike of COVID-19 cases with 2,61,500 fresh cases and 1,501 COVID-related deaths.

As many as 85,620 samples were tested for the virus, including 56,015 RTPCR/CBNAAT/TrueNath tests and 29,605 Rapid antigen tests. The tests per million stand at 8,54,105.

New Delhi: India reported its highest-ever single-day spike of COVID-19 cases with over 2.61 lakh new cases and more than...

Uttar Pradesh is leading in terms of second doses with 15,60,116 second doses being administered so far in the State. It is followed by Gujarat at 13,51,100 and Rajasthan at 13,16,216.

Some major Pharma companies have announced voluntary price cuts for Remdesivir Injections after Centre's intervention to ensure it's affordable availability.

According to the Indian Council of Medical Research, 14,95,397 samples were tested on Friday. And, as many as 26,49,72,022 samples have been tested across the country till April 16.

The team of experts, led by the University of Oxford's Trish Greenhalgh, reviewed published research and identified 10 lines of evidence to support the predominance of the airborne route.